Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease

被引：0
|
作者：
Stefan Schreiber
Axel Dignass
Laurent Peyrin-Biroulet
Greg Hather
Dirk Demuth
Mahmoud Mosli
Rebecca Curtis
Javaria Mona Khalid
Edward Vincent Loftus
机构：
[1] Christian-Albrechts-University,Department of Internal Medicine I and Institute of Clinical Molecular Biology, University
[2] Goethe University,Hospital Schleswig
[3] Lorraine University,Holstein
[4] Takeda Oncology,Department of Medicine 1, Agaplesion Markus Hospital
[5] Takeda Global Research and Development,Inserm U954 and Gastroenterology Department, Nancy University Hospital
[6] Takeda International-UK Branch,Global Medical Affairs
[7] King Abdulaziz University,Department of Medicine
[8] Mayo Clinic College of Medicine,Department of Gastroenterology and Hepatology
来源：
Journal of Gastroenterology | 2018年 / 53卷
关键词：
Vedolizumab; Inflammatory bowel disease; Ulcerative colitis; Crohn’s disease; Real-world effectiveness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1048 / 1064
页数：16
相关论文
共 50 条
  • [31] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Anjur, Kavya
    Neiman, Nicole
    Kotzen, Alison
    Pond, Stephen
    Goyal, Alka
    GASTROENTEROLOGY, 2022, 162 (07) : S826 - S826
  • [32] REAL-WORLD EFFECTIVENESS AND SAFETY OF USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Taxonera, Carlos
    Olivares, David D.
    Lopez-Garcia, Olga N.
    Alba, Cristina
    GASTROENTEROLOGY, 2023, 164 (06) : S1119 - S1119
  • [33] Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis
    Taxonera, Carlos
    Olivares, David
    Alba, Cristina
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (01) : 32 - 40
  • [34] Real-world effectiveness and safety of ustekinumab in patients with ulcerative colitis: a systematic review and meta-analysis
    Taxonera, C.
    Olivares, D.
    Olga, L. G.
    Alba, C.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 652 - 654
  • [35] Systematic Review and Meta-analysis: Vedolizumab and Postoperative Complications in Inflammatory Bowel Disease
    Yung, Diana E.
    Horesh, Nir
    Lightner, Amy L.
    Ben-Horin, Shomron
    Eliakim, Rami
    Koulaouzidis, Anastasios
    Kopylov, Uri
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (11) : 2327 - 2338
  • [36] Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies
    Macaluso, Fabio Salvatore
    Ventimiglia, Marco
    Orlando, Ambrogio
    JOURNAL OF CROHNS & COLITIS, 2023, 17 (08): : 1217 - 1227
  • [37] Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies
    Macaluso, F. S.
    Ventimiglia, M.
    Orlando, A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 857 - 858
  • [38] Systematic Review and Meta-analysis Evaluating the Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease
    Hosack, T.
    Gadhok, R.
    Lindsay, J. O.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I523 - I523
  • [39] Systematic Review and Meta-analysis Evaluating the Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease
    Hosack, T.
    Gadhok, R.
    Lindsay, J. O.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I523 - I523
  • [40] Efficacy and safety of vedolizumab in the treatment of patients with inflammatory bowel disease: A systematic review and meta-analysis of randomized controlled trials
    Tang, Hui-Jun
    Bie, Cai-Qun
    Guo, Li-Liangzi
    Zhong, Li-Xian
    Tang, Shao-Hui
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 25 (06)
12345